According to West Pharmaceutical's latest financial reports the company's current EPS (TTM) is 6,85 โฌ. In 2022 the company made an earnings per share (EPS) of 7,18 โฌ a decrease over its 2021 EPS that were of 8,14 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 6,97 โฌ | -2.85% |
2022 | 7,18 โฌ | -11.77% |
2021 | 8,14 โฌ | 90.19% |
2020 | 4,28 โฌ | 43.43% |
2019 | 2,98 โฌ | 16.79% |
2018 | 2,55 โฌ | 36.59% |
2017 | 1,87 โฌ | 4.59% |
2016 | 1,79 โฌ | 47.37% |
2015 | 1,21 โฌ | -25.7% |
2014 | 1,63 โฌ | 10.84% |
2013 | 1,47 โฌ | 36.29% |
2012 | 1,08 โฌ | 5.8% |
2011 | 1,02 โฌ | 14.29% |
2010 | 0,89 โฌ | -10.91% |
2009 | 1,00 โฌ | -16.98% |
2008 | 1,21 โฌ | 22.69% |
2007 | 0,99 โฌ | 3.85% |
2006 | 0,95 โฌ | 40.54% |
2005 | 0,68 โฌ | 29.82% |
2004 | 0,52 โฌ | -23.49% |
2003 | 0,68 โฌ | 129.23% |
2002 | 0,30 โฌ | -451.35% |
2001 | -0,08438 โฌ | -470% |
2000 | 0,02280 โฌ | -95.82% |
1999 | 0,55 โฌ | 581.58% |
1998 | 0,08006 โฌ | -85.87% |
1997 | 0,57 โฌ | 169% |
1996 | 0,21 โฌ |